Sharps Technology Strengthens Position in Pre-Fillable Syringe Industry with Key Acquisitions and Worldwide Sales Agreement
In a significant move to solidify its presence in the pre-fillable syringe (PFS) market, Sharps Technology has made substantial strides with a series of acquisitions and strategic partnerships. The company, known for its commitment to safe and innovative drug delivery systems, has cemented its standing as a major player in the industry.
The first major milestone in this strategic progression was the acquisition of InjectEZ, which has allowed Sharps Technology to establish its position in the PFS industry in the United States. To secure the purchase exclusivity, the company made a deposit of $1 million into a third-party escrow account, demonstrating its commitment to the venture. With this acquisition, Sharps Technology strengthens its manufacturing capacity and expands its capabilities in the prefillable syringe market.
Continuing on this path of growth, Sharps Technology has also signed a 5-year, $200 million syringe sales agreement and an amendment to an existing asset purchase agreement. This move will enable the company to begin producing prefillable specialty copolymer syringes in the United States. With this additional investment of $35 million into acquiring assets, Sharps Technology secures its position in the specialized copolymer PFS system industry, further bolstering its manufacturing capabilities.
In an exciting development that has garnered industry attention, Sharps Technology has entered into a worldwide sales and distribution agreement with Roncadelle Operations. This strategic partnership will allow the companies to collaborate on selling and distributing their innovative portfolio of safe and technologically advanced drug delivery systems on a global scale. The partnership aims to promote the Securegard, SAFER, and Sologard lines of disposable smart safety syringes. By combining their market reach, Sharps Technology and Roncadelle Operations have significantly expanded their global market presence.
With these momentous acquisitions and partnership agreements, Sharps Technology has positioned itself as a leading force in the pre-fillable syringe industry. The company’s dedication to providing secure and innovative drug delivery systems has been further amplified. In an ever-evolving healthcare landscape, the partnership with Roncadelle Operations and the acquisition of assets have not only bolstered the company’s manufacturing capabilities but also expanded its market reach on a worldwide scale.
Comments